Experimental drug combination shows potential for triple-negative breast cancer
Researchers from Vanderbilt-Ingram Cancer Center, USA, discovered a role for MYCN in triple-negative breast cancer…
Browsing: triple-negative breast cancer
Possible treatment for breast cancer patients could roll out to clinical trial immediately
A worldwide collaborative study led by scientists at the University of Sussex, UK, has proposed…
Both BRCA1-wild type and mutant triple-negative breast cancers show
Oncotarget features “MLN4924 treatment induces DNA damage by stabilising CDT1 and accumulates the cells in S…
Study finds inflammation caused by radiation can drive triple-negative breast cancer
While radiation is successfully used to treat breast cancer by killing cancer cells, inflammation caused…
New insights into cause and treatments for aggressive form of breast cancer
Potential environmental risk factors and new targets for treating an aggressive form of breast cancer…
Preclinical study reveals the impact of age on immunotherapy treatment for breast cancer
Recent clinical trials have indicated that immune checkpoint blockade (ICB) therapy, which is designed to…
New hope for aggressive breast cancers as diabetes drug creates treatment ‘sweet spot’
A drug commonly used to treat Type 2 diabetes can force breast cancer ‘stem cells’…
Triple-negative breast cancer among black women in the US varies by birthplace
A new study finds substantial variation in the prevalence of triple-negative breast cancer among black…
Obesity reprograms immune cells in breasts to promote tumour formation
Smoking has long been the biggest cause of cancer in the United States, but obesity,…
Preventing triple negative breast cancer from spreading
A breast cancer cell is like a house with three locks on the front door.…